- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
3
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
UTHR | US$364.33 | -9.0% | 58.1% | US$16.1b | US$382.29 | PE14.6x | E8.1% | n/a | ||
INVA | US$19.15 | -4.7% | 41.1% | US$1.2b | US$19.00 | PE18.6x | S6.4% | 0% | ||
DMTK.Q | US$0.000001 | 0% | -100.0% | US$35.0 | n/a | PS0.000002x | n/a | n/a |
Page 1 of 1